StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen marketable securities ($M) ($M)

Form 10-Q / 10-K (DB)

QuarterlyAnnual
Latest, Q4 2023
0
Period ended Dec 31, 2023
Change on a year earlier
-100.0%
1,676 in Q4 2022
History
22 quarters
Since Q4 2017
Sources
21
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMarketable securities ($M) ($M)Year on yearSource
Q4 2023Dec 31, 20230-100.0%Form 10-K (filed 2024-02-14) ↗
Q3 2023Sep 30, 20230-100.0%Form 10-Q (filed 2023-10-31) ↗
Q2 2023Jun 30, 20230-100.0%Form 10-Q (filed 2023-08-04) ↗
Q1 2023Mar 31, 20231-93.7%Form 10-Q (filed 2023-04-28) ↗
Q4 2022Dec 31, 20221,676+3,391.7%Form 10-K (filed 2023-02-09) ↗
Q3 2022Sep 30, 20221,976+107.6%Form 10-Q (filed 2022-11-04) ↗
Q2 2022Jun 30, 20221,980–Form 10-Q (filed 2022-08-05) ↗
Q1 2022Mar 31, 202216-99.6%Form 10-Q (filed 2022-04-28) ↗
Q4 2021Dec 31, 202148-98.9%Form 10-K (filed 2022-02-16) ↗
Q3 2021Sep 30, 2021952-70.9%Form 10-Q (filed 2021-11-03) ↗
Q1 2021Mar 31, 20214,454+1,270.5%Form 10-Q (filed 2021-04-28) ↗
Q4 2020Dec 31, 20204,381+52.4%Form 10-K (filed 2021-02-09) ↗
Q3 2020Sep 30, 20203,273–Form 10-Q (filed 2020-10-29) ↗
Q2 2020Jun 30, 20202,276-86.0%Form 10-Q (filed 2020-07-29) ↗
Q1 2020Mar 31, 2020325-98.3%Form 10-Q (filed 2020-05-01) ↗
Q4 2019Dec 31, 20192,874-87.1%Form 10-K (filed 2020-02-12) ↗

Cite this data

StockData. (2026). Amgen Marketable securities ($M) ($M), quarterly Q4 2017–Q4 2023 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_st_inv

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.